HU0500920D0 - New compounds - Google Patents

New compounds

Info

Publication number
HU0500920D0
HU0500920D0 HU0500920A HUP0500920A HU0500920D0 HU 0500920 D0 HU0500920 D0 HU 0500920D0 HU 0500920 A HU0500920 A HU 0500920A HU P0500920 A HUP0500920 A HU P0500920A HU 0500920 D0 HU0500920 D0 HU 0500920D0
Authority
HU
Hungary
Prior art keywords
new compounds
compounds
new
Prior art date
Application number
HU0500920A
Other languages
Hungarian (hu)
Original Assignee
Richter Gedeon Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet
Priority to HU0500920A priority Critical patent/HUP0500920A2/en
Publication of HU0500920D0 publication Critical patent/HU0500920D0/en
Priority to PCT/HU2006/000087 priority patent/WO2007039781A2/en
Publication of HUP0500920A2 publication Critical patent/HUP0500920A2/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
HU0500920A 2005-10-05 2005-10-05 Oxadiazole derivatives, process for their preparation and their use HUP0500920A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
HU0500920A HUP0500920A2 (en) 2005-10-05 2005-10-05 Oxadiazole derivatives, process for their preparation and their use
PCT/HU2006/000087 WO2007039781A2 (en) 2005-10-05 2006-10-05 New compounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU0500920A HUP0500920A2 (en) 2005-10-05 2005-10-05 Oxadiazole derivatives, process for their preparation and their use

Publications (2)

Publication Number Publication Date
HU0500920D0 true HU0500920D0 (en) 2005-12-28
HUP0500920A2 HUP0500920A2 (en) 2007-07-30

Family

ID=89986317

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0500920A HUP0500920A2 (en) 2005-10-05 2005-10-05 Oxadiazole derivatives, process for their preparation and their use

Country Status (2)

Country Link
HU (1) HUP0500920A2 (en)
WO (1) WO2007039781A2 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20090095648A (en) 2006-12-15 2009-09-09 아보트 러보러터리즈 Novel oxadiazole compounds
US8349852B2 (en) 2009-01-13 2013-01-08 Novartis Ag Quinazolinone derivatives useful as vanilloid antagonists
US20120040998A1 (en) * 2009-04-23 2012-02-16 Mercer Swati P 2-alkyl piperidine mglur5 receptor modulators
WO2011020116A1 (en) 2009-08-14 2011-02-17 University Of Virginia Patent Foundation Imidamide sphingosine kinase inhibitors
CA2784768C (en) * 2009-12-29 2015-02-03 Eli Lilly And Company Tetrahydrotriazolopyridine compounds as selective mglu5 receptor potentiators useful for the treatment of schizophrenia
AR080056A1 (en) 2010-02-01 2012-03-07 Novartis Ag CICLOHEXIL-AMIDA DERIVATIVES AS ANTAGONISTS OF CRF RECEIVERS
US20120295942A1 (en) 2010-02-01 2012-11-22 Nicholas James Devereux Pyrazolo[5,1b]oxazole Derivatives as CRF-1 Receptor Antagonists
CN102753527B (en) 2010-02-02 2014-12-24 诺华股份有限公司 Cyclohexyl amide derivatives as crf receptor antagonists
WO2012052489A1 (en) 2010-10-21 2012-04-26 Bayer Cropscience Ag 1-(heterocyclic carbonyl) piperidines
TWI510481B (en) 2012-06-04 2015-12-01 Actelion Pharmaceuticals Ltd Benzimidazole-proline derivatives
AU2013328301A1 (en) 2012-10-10 2015-05-28 Actelion Pharmaceuticals Ltd Orexin receptor antagonists which are [ortho bi (hetero-)aryl]-[2-(meta bi (hetero-)aryl)-pyrrolidin-1-yl]-methanone derivatives
JP2016510810A (en) 2013-03-12 2016-04-11 アクテリオン ファーマシューティカルズ リミテッドＡｃｔｅｌｉｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｌｔｄ Azetidine amide derivatives as orexin receptor antagonists
HUE040555T2 (en) 2013-12-04 2019-03-28 Idorsia Pharmaceuticals Ltd Use of benzimidazole-proline derivatives
WO2020154431A1 (en) * 2019-01-25 2020-07-30 Lynch Kevin R Inhibitors of spinster homolog 2 (spns2) for use in therapy
WO2022056042A1 (en) * 2020-09-09 2022-03-17 University Of Virginia Patent Foundation Inhibitors of spinster homolog 2 (spns2) for use in therapy

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19643037A1 (en) * 1996-10-18 1998-04-23 Boehringer Ingelheim Kg New oxadiazoles, processes for their preparation and their use as medicines
US7217714B1 (en) * 1998-12-23 2007-05-15 Agouron Pharmaceuticals, Inc. CCR5 modulators
US6596731B2 (en) * 2001-03-27 2003-07-22 Hoffmann-La Roche Inc. Substituted imidazo[1,2-A] pyridine derivatives
EP1581525A2 (en) * 2002-08-09 2005-10-05 AstraZeneca AB Compounds having an activity at metabotropic glutamate receptors
GB0325956D0 (en) * 2003-11-06 2003-12-10 Addex Pharmaceuticals Sa Novel compounds

Also Published As

Publication number Publication date
WO2007039781A3 (en) 2010-08-26
HUP0500920A2 (en) 2007-07-30
WO2007039781A2 (en) 2007-04-12

Similar Documents

Publication Publication Date Title
GB0503962D0 (en) Compounds
GB0502418D0 (en) Compounds
GB0502316D0 (en) Compounds
EP1961741A4 (en) m-CARBAZOLYLPHENYL COMPOUNDS
HU0500920D0 (en) New compounds
HK1121755A1 (en) New compounds iii
GB0502310D0 (en) Compounds
GB0502299D0 (en) Compounds
HU0500921D0 (en) New compounds
EP1934217A4 (en) New compounds ii
AP2007004220A0 (en) Motilide compounds
GB0505084D0 (en) Compounds
GB0503961D0 (en) Compounds
EP1907385A4 (en) Compounds
GB0505086D0 (en) Compounds
HU0501170D0 (en) New compounds
HU0501168D0 (en) New compounds
HU0500886D0 (en) New compounds
HU0500879D0 (en) New compounds
HU0500877D0 (en) New compounds
GB0501985D0 (en) Compounds
EP1867650A4 (en) Hydroxymethylboron compounds
GB0505085D0 (en) Compounds
GB0501984D0 (en) Compounds
HU0501166D0 (en) New compounds

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees